As an alternative, some doctors have been prescribing metformin—an oral diabetes drug—off-label for weight loss ... says ...

The FDA had proposed removing phenylephrine, a widely used ingredient to treat nasal congestion, from over-the-counter cold ...

The Company reported a net loss of approximately $8.4 million, or $0.25 per share, for the three months ended September 30, 2024, compared to a net loss of approximately $11.3 million, or $0.48 per ...

The treatment is the first approved gene therapy for AADC deficiency, the FDA said. People with this rare disorder have ...

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced that the Company requested a post-complete letter clarification ...

Obe-cel is the first FDA-approved CAR T-cell therapy for B-ALL without a REMS ... offering an attractive risk benefit profile ...

“We are pleased to have been granted Orphan Drug designation by the US FDA for AT-02 in ATTR amyloidosis,” said Gregory Bell, MD, Chief Medical Officer at Attralus. “Current approved therapies for ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...

Investigational nipocalimab reduced serum immunoglobulin G (IgG), improved functional scores, and was well tolerated in ...